Skip to content

A new state-of-the-art facility specializing in breast and gynecologic cancers will open its doors at Stanford on June 27. The 13,800-square-foot center will be housed …

Published on

Stanford researchers just announced that by using a new antibody against a cell protein called CD47, along with an existing anti-cancer antibody, they were able to cure well over half of the mice that had been given a human leukemia called non-Hodgkins lymphoma.

Stanford researchers just announced that by using a new antibody against a cell protein called CD47, along with an existing anti-cancer antibody, they were able to cure well over half of the mice that had been given a human leukemia called non-Hodgkins lymphoma.